A Case of Rheumatoid Arthritis and Limited Systemic Sclerosis Overlap Successfully Treated with Tocilizumab for Arthritis and Concomitant Generalized Lymphadenopathy and Primary Biliary Cirrhosis

<table>Clinical course and changes in articular manifestations, lymph node swelling, and serum ALP, <i>γ</i>-GTP concentration. The improvements of articular manifestations, lymph node swelling, and serum ALP, <i>γ</i>-GTP concentration were closely linked to TCZ therapy.</table>

Case Reports in Rheumatology

fig3

Figure 3

Figure 3: A Case of Rheumatoid Arthritis and Limited Systemic Sclerosis Overlap Successfully Treated with Tocilizumab for Arthritis and Concomitant Generalized Lymphadenopathy and Primary Biliary Cirrhosis 

Figure 3 | A Case of Rheumatoid Arthritis and Limited Systemic Sclerosis Overlap Successfully Treated with Tocilizumab for Arthritis and Concomitant Generalized Lymphadenopathy and Primary Biliary Cirrhosis 